JD Health International revenue and financials
$35.34Change from previous close: +0.57%Absolute change: +$0.20
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 10,174 | 4,332 | 4,605 | 5,905 | — |
| Depreciation and amortization | 280 | 215 | 227 | 141 | — |
| Capital expenditure | -151 | -46.4 | -69.3 | -2,273 | — |
| Investing cash flow | -591 | 3,146 | -8,023 | -4,236 | — |
| Financing cash flow | -79.2 | -45.6 | -117 | -925 | — |
| Share repurchases | — | 0.0 | -69.1 | -869 | -56.3 |
| Debt repaid | — | — | — | — | 0.0 |
| Effect of exchange rates | -348 | 159 | -145 | 721 | — |
| Net change in cash | 9,504 | 7,433 | -3,535 | 744 | — |
| Free cash flow | 10,023 | 4,286 | 4,535 | 3,632 | — |